IFRX - InflaRx prices $40M offering

2023-04-12 02:57:39 ET

• Clinical-stage biopharmaceutical company developing anti-inflammatory therapeutics by targeting the complement system,InflaRx N.V. ( NASDAQ: IFRX ) priced its underwritten public offering of ~9.42M shares at an offering price of $4.25 per share.
• The offering is expected to close on April 14, 2023.
• Underwriters' have 30-day option to purchase up to ~1.41M additional shares.
• Net proceeds to fund the continued development of vilobelimab, general research and development expenses and investments in the company’s commercial infrastructure and for working capital and general corporate purposes.
• Stock price marginally up 0.40% .

For further details see: